This inventor holds 6 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Orion Corporation, Orlon Corporation. Active years: 2014-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2020
Title: Terhi Heikkinen: Innovator in Medicinal Chemistry from Lieto, FI
Introduction
Terhi Heikkinen is a prominent inventor based in Lieto, Finland, known for her significant contributions to the field of medicinal chemistry. With a total of six patents to her name, she has made remarkable advancements in the development of pharmaceutical compounds, particularly for androgen receptor modulation.
Latest Patents
Among her notable inventions, Terhi's latest patents focus on carboxamide derivatives and their diastereomers in stable crystalline forms. These inventions relate to the solid crystalline forms of N—((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide. These compounds are highlighted for their potency as androgen receptor (AR) modulators, indicating their potential utility as medicaments.
Career Highlights
Throughout her career, Terhi Heikkinen has worked with well-respected companies in the pharmaceutical industry, such as Orion Corporation and Orlon Corporation. Her work in these organizations has allowed her to develop her expertise and drive progress in medicinal chemistry, focusing on drug development and formulation.
Collaborations
In her professional journey, Terhi has collaborated with notable colleagues, including Olli Törmäkangas and Harri Salo. These partnerships have fostered innovation and enhanced research in the fields of chemistry and pharmaceuticals, contributing to the success of Terhi's research endeavors.
Conclusion
Terhi Heikkinen continues to be a leading figure in the innovation of medicinal compounds, proving that her work has significant implications for the development of new therapeutic options. Her ongoing research and patent contributions illustrate her commitment to advancing the field of medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
